Alvotech
Biotechnology Research-, Iceland501-1000 Employees
Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars.
Insights
Biosimilar Expansion Alvotech has recently launched several biosimilar products, such as AVT29, UZPROVO, and Stelara biosimilar in various countries. These product launches indicate a growing market presence and potential for expanding sales opportunities globally.
Collaborative Partnerships Partnerships with companies like Dr. Reddy's Laboratories and Quallent Pharmaceuticals Health demonstrate Alvotech's commitment to strategic collaborations. Leveraging these relationships can offer avenues for joint sales efforts and market penetration.
Revenue Potential With a revenue ranging between $100M to 1B and significant funding of $965M, Alvotech presents a financially stable platform for sales growth. This financial strength can support aggressive sales strategies and business development initiatives.
Technological Integration Utilizing a diverse tech stack including SAP, Java, and Cisco, Alvotech showcases a commitment to technological advancement. Leveraging these tools effectively can streamline sales processes, enhance customer interactions, and drive revenue growth.
Competitive Positioning In a competitive landscape with companies like Aurobindo Pharma, Sanofi, and Pfizer, Alvotech's focus on biosimilars and strategic product launches position it well for differentiation. Identifying key competitive advantages can drive targeted sales strategies and market positioning.
Similar companies to Alvotech
Aurobindo Pharma
6.3K
$100M$1BSanofi
87K$1BCoherus BioSciences
303$50M$100MDr. Reddy's Laboratories
27K$1BPfizer
102K$1BGenentech
18K$1BMylan
15K$1BAccord Healthcare
1.9K$100M$1BBiogen
8.1K$1BSandoz
17K$1BAmgen
36K$1BHikma Pharmaceuticals
8.9K$1B
Alvotech Tech Stack
Alvotech uses 8 technology products and services including Cookiebot, PFS, amCharts, and more. Explore Alvotech's tech stack below.
- CookiebotCookie Compliance
- PFSE-commerce Platforms
- amChartsJavascript Graphics
- CiscoNetwork Hardware
- PHPProgramming Languages
- HSTSSecurity
- MinitabVisualisation Software
- FlexSliderWidgets
Media & News
Alvotech's Email Address Formats
Alvotech uses at least 1 format(s):
| Alvotech Email Formats | Percentage |
| First.Last@alvotech.com | 98% |
| FirstLa@alvotech.com | 1% |
| First@alvotech.com | 1% |
Frequently Asked Questions
Where is Alvotech's headquarters located?
Alvotech's main headquarters is located at Saemundargata 15-19 Reykjavik, - 101 IS. The company has employees across 5 continents, including EuropeAsiaNorth America. What is Alvotech's phone number?
You can contact Alvotech's main corporate office by phone at +354-522-****
What is Alvotech's stock symbol?
Alvotech is a publicly traded company; the company's stock symbol is ALVO. What is Alvotech's official website and social media links?
Alvotech's official website is alvotech.com and has social profiles on LinkedIn.How much revenue does Alvotech generate?
As of November 2024, Alvotech's annual revenue reached $750M. What is Alvotech's SIC code NAICS code?
Alvotech's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Alvotech have currently?
As of November 2024, Alvotech has approximately 881 employees across 5 continents, including EuropeAsiaNorth America. Key team members include Chief Executive Officer: R. W.Chief Technical Officer: G. Z.Chief Commercial Officer: A. O.. Explore Alvotech's employee directory with LeadIQ.What industry does Alvotech belong to?
Alvotech operates in the Biotechnology Research industry. What technology does Alvotech use?
Alvotech's tech stack includes CookiebotPFSamChartsCiscoPHPHSTSMinitabFlexSlider. What is Alvotech's email format?
Alvotech's email format typically follows the pattern of . Find more Alvotech email formats with LeadIQ. How much funding has Alvotech raised to date?
As of November 2024, Alvotech has raised $965M in funding. The last funding round occurred on Jun 07, 2024 for $965M.When was Alvotech founded?
Alvotech was founded in 2013.
Company Overview
- Headquarters
- Saemundargata 15-19 Reykjavik, - 101 IS
- Phone number
- +354-522-****
- Website
- alvotech.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- Stock Symbol
- ALVO
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2013
- Employees
- 501-1000
Media & News
Funding & Financials
- $965M
Alvotech has raised a total of $965M of funding over 8 rounds. Their latest funding round was raised on Jun 07, 2024 in the amount of $965M.
- $100M$1B
Alvotech's revenue is in the range of $100M$1B
Funding & Financials
- $965M
Alvotech has raised a total of $965M of funding over 8 rounds. Their latest funding round was raised on Jun 07, 2024 in the amount of $965M.
- $100M$1B
Alvotech's revenue is in the range of $100M$1B
Company Leadership
R. W.Chief Executive Officer
G. Z.Chief Technical Officer- A. O.Chief Commercial Officer
- A. M.Chief Regulatory Affairs Officer
- F. K.Chief Operating Officer
Employee Directory
- A. O.Chief Commercial Officer
- A. M.Chief Regulatory Affairs Officer
- F. K.Chief Operating Officer
G. R. D. J.Head Of Cmo And Launch Management- H. G.Head Of Cmo Management
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
